You are currently viewing a new version of our website. To view the old version click .
  • Indexed inScopus
  • 21 daysTime to First Decision

Most Cited

  • Review
  • Open Access
16 Citations
7,635 Views
31 Pages

2 January 2025

The integration of small interfering RNA (siRNA) with traditional cancer therapies represents a promising frontier in oncology aimed at enhancing treatment effectiveness, reducing side effects, and overcoming drug resistance. This review highlights t...

  • Review
  • Open Access
9 Citations
6,821 Views
29 Pages

A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers

  • Fnu Amisha,
  • Paras Malik,
  • Prachi Saluja,
  • Nitesh Gautam,
  • Tanvi Harishbhai Patel,
  • Arya Mariam Roy,
  • Sunny R. K. Singh and
  • Sindhu Janarthanam Malapati

26 May 2023

The human epidermal growth factor receptors (HERs) are expressed abundantly in the human body. The tumorigenic potential of HER2/neu is linked to its overexpression, amplification or somatic mutation. The HER2 gene amplification leading to protein ov...

  • Review
  • Open Access
5 Citations
5,798 Views
18 Pages

26 September 2024

The epidermal growth factor receptor (EGFR) plays a critical role in regulating essential cellular processes that are frequently hijacked to promote cancer. In colorectal cancer (CRC) in particular, the EGFR signaling pathway is frequently hyperactiv...

  • Review
  • Open Access
5 Citations
3,748 Views
30 Pages

Molecular Insight and Antioxidative Therapeutic Potentials of Plant-Derived Compounds in Breast Cancer Treatment

  • Sandhya Shukla,
  • Arvind Kumar Shukla,
  • Adarsha Mahendra Upadhyay,
  • Navin Ray,
  • Fowzul Islam Fahad,
  • Arulkumar Nagappan,
  • Sayan Deb Dutta and
  • Raj Kumar Mongre

9 June 2025

Breast cancer is one of the most common and difficult-to-treat cancers affecting women globally. Long-term treatment success is still limited by problems like drug resistance, toxicity, and recurrence, even with advancements in conventional therapies...

  • Review
  • Open Access
4 Citations
11,953 Views
22 Pages

9 January 2024

In multiple myeloma (MM), specific cytokines produced by plasma cells disrupt the equilibrium between osteoblasts and osteoclasts. As a result, MM patients experience an increase in osteoclast activity and a decrease in osteoblast activity. This disp...

  • Review
  • Open Access
4 Citations
5,767 Views
12 Pages

Clinical Evidence of Methods and Timing of Proper Follow-Up for Head and Neck Cancers

  • Riccardo Gili,
  • Simone Caprioli,
  • Paola Lovino Camerino,
  • Gianluca Sacco,
  • Tommaso Ruelle,
  • Daria Maria Filippini,
  • Silvia Pamparino,
  • Stefania Vecchio,
  • Filippo Marchi and
  • Lucia Del Mastro
  • + 1 author

29 September 2024

Background: For patients with head and neck squamous cell carcinoma (HNSCC), after a single or multi-modality treatment, a specific follow-up strategy is needed, but there is no agreement between the main international societies on the proper methods...

  • Review
  • Open Access
4 Citations
5,132 Views
11 Pages

Perfusion Bioreactor Technology for Organoid and Tissue Culture: A Mini Review

  • Paola Avena,
  • Lucia Zavaglia,
  • Ivan Casaburi and
  • Vincenzo Pezzi

9 April 2025

Organoid culture is an emerging and promising 3D culture system by which three-dimensional cell aggregates have been produced from different organs and tissues. This new innovative culture technology preserves parental gene expression, as well as the...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Onco - ISSN 2673-7523